Prescription Drug Recall: Jardiance Empagliflozin 25 mg Label Mix-Up
Boehringer Ingelheim Pharmaceuticals is recalling Jardiance (Empagliflozin) 25 mg tablets due to a label mix-up affecting 69,375 bottles distributed nationwide.
- Product
- JARDIANCE — JARDIANCE (EMPAGLIFLOZIN)
- Category
- Drug
- Distribution
- Distributed nationwide